GlassScriptPhysician profile
Rohit Sundrani
NPI 1508835463
$86,203.01
in general payments reported to CMS, 2019-2025
23 companies · $11K in 2025
The $11K reported for 2025 was more than what 95% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $9,114 · 2021: $15K · 2022: $19K · 2023: $8,129 · 2024: $6,077 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $20K · Food and Beverage: $2,749 · Travel and Lodging: $2,602 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $19,602.00 |
| Food and Beverage | $2,749.07 |
| Travel and Lodging | $2,601.95 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $38,605.65 | 2019-2022 | |
| Amgen INC. | $23,781.42 | 2019-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $10,927.73 | 2019-2022 | |
| Abbott Laboratories | $4,892.90 | 2019-2024 | Mitraclip, Amplatzer Talisman, Aveir |
| Edwards Lifesciences Corporation | $3,635.75 | 2019-2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Medtronic Vascular, INC. | $1,424.58 | 2019-2020 | |
| Medtronic, INC. | $1,256.84 | 2021-2023 | In.Pact Admiral |
| Abiomed | $412.10 | 2019-2022 | |
| Actelion Pharmaceuticals US, INC. | $353.35 | 2019-2022 | |
| Shockwave Medical, INC | $223.57 | 2021-2022 | |
| Boston Scientific Corporation | $216.21 | 2019-2020 | |
| Kiniksa Pharmaceuticals, LTD. | $108.09 | 2022-2023 | Arcalyst |
| Inari Medical, INC. | $78.03 | 2021 | |
| Cardiovascular Systems INC. | $54.19 | 2019 | |
| Pfizer INC. | $42.71 | 2021-2024 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $35.82 | 2019 | |
| Merck Sharp & Dohme LLC | $30.62 | 2024 | Winrevair |
| Philips North America LLC | $29.03 | 2025 | Igt Devices Systems Undivided |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.55 | 2023 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $20.00 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.28 | 2022 | |
| Inspire Medical Systems, INC. | $18.05 | 2023 | Inspire |
| Gilead Sciences, INC. | $17.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rohit Sundrani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.